Irnocam 40 mg Injection
8,81$
7,11$
Irnocam 40 mg injection is a powerful topoisomerase inhibitor specifically designed for the treatment of advanced colorectal cancer. This medication can be administered as a standalone therapy or in combination with 5-fluorouracil and folinic acid, particularly for patients who have not undergone prior chemotherapy for their advanced disease. By disrupting the DNA replication process in cancer cells, Irnocam effectively slows tumor growth and progression, making it an essential option in the first-line treatment of metastatic carcinoma of the colon or rectum. It’s important to be aware of potential side effects, including severe diarrhea and low blood cell counts, which require careful monitoring during treatment. Patients should discuss their medical history with their healthcare provider to ensure the safe use of Irnocam. With its targeted action and proven efficacy, Irnocam offers hope for those battling this challenging condition, improving outcomes and enhancing the quality of life for many. Always consult with a healthcare professional before starting any new treatment to understand the best options for your specific situation.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Irnocam 40 mg injection is primarily used in the treatment of certain types of cancer, particularly colorectal cancer. It functions as a chemotherapeutic agent that helps to inhibit cancer cell growth and division. This injection is often part of a combination therapy approach, where it is used alongside other medications to enhance treatment efficacy. Patients receiving Irnocam 40 mg injection typically do so in a controlled clinical environment.
• In addition to colorectal cancer, Irnocam 40 mg injection may be utilized for other malignancies as determined by a healthcare provider. The medication plays a critical role in managing advanced stages of cancer, where aggressive treatment is necessary. By targeting the cancer cells directly, Irnocam 40 mg injection helps to slow down disease progression. Oncologists evaluate the specific cancer type and patient condition to incorporate this injection into the treatment plan.
• Irnocam 40 mg injection is administered intravenously by trained medical professionals, ensuring precise delivery of the medication. This method allows for immediate absorption into the bloodstream, enhancing its effectiveness against cancer cells. The administration typically occurs in a hospital or outpatient setting, providing continuous monitoring of the patient's response. This careful approach maximizes the potential benefits of Irnocam 40 mg injection while minimizing complications.
• Healthcare providers often recommend Irnocam 40 mg injection as part of a comprehensive cancer treatment strategy. The use of this injection is tailored to each patient’s unique circumstances, including their overall health and treatment history. By integrating Irnocam 40 mg injection into the regimen, oncologists aim to improve patient outcomes and manage symptoms effectively. Regular assessments help in adjusting the treatment as needed, ensuring optimal care throughout the cancer journey.
Benefits
Treatment of colon and rectum cancer: Cancer of the colon and rectum, also known as colorectal cancer (CRC) or bowel cancer, is the development of cancer from two parts of the large intestine, namely, the colon or rectum. In this type of cancer, the person may notice symptoms such as blood in the stool, a change in bowel movements, weight loss, and fatigue. Irnocam 40 mg Injection treats and also lowers the risk of developing further cancerous growths (polyps) and bowel cancer. It kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.
Side Effects
Like all medications, Anti-cancer Drug Irnocam can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.
Most Common Side Effects
• Nausea
• Vomiting
• Constipation
• Fever
• Infection
• Pain
Common Side Effects
• Diarrhea
• Kidney Impairment
• Lung Problems
• Low blood count
How To Use
Irinotecan Injection 40 mg is administered by a qualified doctor or nurse at a hospital or clinical setting. It is given intravenously and is usually given as part of a combination chemotherapy regimen. The specific treatment plan and dosage will depend on the type and stage of the cancer being treated, as well as other individual factors determined by the healthcare provider.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Irnocam 40 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Irnocam 40 mg Injection should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Irnocam 40 mg and report any unusual symptoms or changes in kidney function to their doctor. Irnocam 40 mg Injection is not recommended for use in patients on dialysis.
• Breastfeeding: The available data are limited but suggest that Irnocam 40 mg Injection and its metabolite are excreted in human milk. Consequently, because of the potential for adverse reactions in nursing infants, breastfeeding should be discontinued for the duration of Irnocam 40 mg Vial therapy.
• Liver: Irinotecan Injection 40 mg should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Anti-cancer Drug Irnocam and report any unusual symptoms or changes in liver function to their doctor. The dose of Irnocam 40 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: There are limited data on the use of irinotecan in pregnant women. Irinotecan Injection 40 mg has been shown to be embryotoxic and teratogenic in animals. Therefore, based on results from animal studies and the mechanism of action of Irnocam 40 mg, Irnocam 40 mg Injection should not be used during pregnancy unless clearly necessary. Women of childbearing potential should not be started on Irnocam Injection until pregnancy is excluded. Pregnancy should be avoided if either partner is receiving Irnocam 40 mg Injection.
• Driving: Irnocam 40 mg Injection has a moderate influence on the ability to drive and use machines. Patients should be warned about the potential for dizziness or visual disturbances, which may occur within 24 hours following the administration of Irnocam Injection, and advised not to drive or operate machinery if these symptoms occur.